(₹ crores) | Q3FY25 | Q2FY25 | Q3FY24 | QoQ (%) | YoY (%) |
---|---|---|---|---|---|
Total Income | 91.15 | 85.43 | 82.57 | 6.7% | 10.4% |
Total Expenses | 67.23 | 63.54 | 69.07 | 5.8% | -2.7% |
Profit Before Tax | 23.92 | 21.89 | 13.50 | 9.3% | 77.2% |
Tax | 6.40 | 4.88 | 3.37 | 31.1% | 89.9% |
Profit After Tax | 21.50 | 15.25 | 10.13 | 41.0% | 112.2% |
Earnings Per Share | 9.60 | 6.80 | 4.50 | 41.2% | 113.3% |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Vimta Labs Ltd is a prominent player in the testing and research services sector, primarily operating in the healthcare and pharmaceuticals industry. The company specializes in offering a wide range of analytical, clinical, and environmental testing services. These services are essential for ensuring compliance with health and safety standards across various industries. As of the data available, Vimta Labs is recognized for its advanced laboratory facilities and a commitment to delivering high-quality testing solutions. There have been no significant recent developments mentioned, but the company has been known for maintaining a strong market presence in its field.
In the third quarter of the fiscal year 2025 (Q3FY25), Vimta Labs Ltd recorded a total income of ₹91.15 crores. This represents a quarter-over-quarter (QoQ) increase of 6.7% from the second quarter of the fiscal year 2025 (Q2FY25), where the total income was ₹85.43 crores. Year-over-year (YoY), this marks a growth of 10.4% compared to the third quarter of the fiscal year 2024 (Q3FY24), when the company reported a total income of ₹82.57 crores. This growth trajectory indicates a consistent improvement in revenue generation over time, reflecting the company's ability to enhance its income streams.
The profitability metrics for Vimta Labs Ltd in Q3FY25 indicate a notable improvement. The company reported a profit before tax (PBT) of ₹23.92 crores, showing a QoQ increase of 9.3% from ₹21.89 crores in Q2FY25. On a YoY basis, the PBT surged by 77.2% from ₹13.50 crores in Q3FY24. The profit after tax (PAT) also demonstrated significant growth, reaching ₹21.50 crores in Q3FY25, which is a 41.0% increase QoQ from ₹15.25 crores in Q2FY25 and a remarkable 112.2% rise YoY from ₹10.13 crores in Q3FY24. This substantial growth in profitability metrics is further reflected in the earnings per share (EPS), which increased to ₹9.60 in Q3FY25 from ₹6.80 in Q2FY25, representing a 41.2% QoQ rise and a 113.3% YoY increase from ₹4.50 in Q3FY24.
Vimta Labs Ltd reported total expenses of ₹67.23 crores in Q3FY25, marking a QoQ increase of 5.8% from ₹63.54 crores in Q2FY25. However, compared to Q3FY24, there is a YoY decrease of 2.7% from ₹69.07 crores. The tax expense for Q3FY25 was ₹6.40 crores, up by 31.1% QoQ from ₹4.88 crores in Q2FY25 and 89.9% YoY from ₹3.37 crores in Q3FY24. These figures highlight the changes in the company's operating costs and tax obligations over the periods compared. The overall increase in expenses QoQ and decrease YoY indicate varying cost management dynamics, while the rise in tax expense reflects changes in the company's taxable income and applicable tax rates.